Retimax by CSO is an innovative technology using multi-focal ERG, PERG and VEP tests for improved detection of retinal diseases.
Retimax identifies retinal dysfunctions within a 20-40 degree area in the retina structure at a very early stage, before perimetric abnormalities in the visual field can be revealed.
Retimax is the ideal tool to identify glaucoma, age related macular degeneration, retinitis pigmentosa and scotoma of very small diameter (a few millimeters only).
The results are fast and easy to read thanks to the test comparison with internal normative database.
Contact: France Medical (AUS) 07 3393 9342
